Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Arnott

Showing results (151-160 of 164) with videos related to

Pageof 17
Sort By:
Journal of the American Heart Association|December 30, 2022
Soluble Epoxide Hydrolase Derived Linoleic Acid Oxylipins, Small Vessel Disease Markers, and Neurodegeneration in StrokeDi Yu, Nuanyi Liang, Julia Zebarth, et al.
Journal of Neurology|June 25, 2025
Regional free-water diffusion is more strongly related to neuroinflammation than neurodegenerationVishaal Sumra, Mohsen Hadian, Allison A Dilliott, et al.
Neurorehabilitation and Neural Repair|June 3, 2023
Association of Dual-Task Gait Cost and White Matter Hyperintensity Burden Poststroke: Results From the ONDRIFrederico Pieruccini-Faria, Benjamin Cornish, Malcolm Binns, et al.
International Journal of Geriatric Psychiatry|March 16, 2024
Neuropsychiatric symptoms and brain morphology in patients with mild cognitive impairment, cerebrovascular disease and Parkinson disease: A cross sectional and longitudinal studyNeda Rashidi-Ranjbar, Nathan W Churchill, Sandra E Black, et al.
European Journal of Neurology|January 24, 2023
White matter hyperintensity burden predicts cognitive but not motor decline in Parkinson's disease: results from the Ontario Neurodegenerative Diseases Research InitiativeDaniela Cristina Carvalho de Abreu, Frederico Pieruccini-Faria, Yanina Sarquis-Adamson, et al.
Geroscience|March 16, 2022
Investigating the contribution of white matter hyperintensities and cortical thickness to empathy in neurodegenerative and cerebrovascular diseasesMiracle Ozzoude, Brenda Varriano, Derek Beaton, et al.
Brain Communications|March 27, 2023
Cognitive correlates of antisaccade behaviour across multiple neurodegenerative diseasesHeidi C Riek, Donald C Brien, Brian C Coe, et al.
Alzheimer'S Research & Therapy|June 20, 2023
White matter hyperintensities and smaller cortical thickness are associated with neuropsychiatric symptoms in neurodegenerative and cerebrovascular diseasesMiracle Ozzoude, Brenda Varriano, Derek Beaton, et al.
BMC Psychiatry|January 23, 2023
AI-based dimensional neuroimaging system for characterizing heterogeneity in brain structure and function in major depressive disorder: COORDINATE-MDD consortium design and rationaleCynthia H Y Fu, Guray Erus, Yong Fan, et al.
Nature. Mental Health|July 1, 2024
Neuroanatomical dimensions in medication-free individuals with major depressive disorder and treatment response to SSRI antidepressant medications or placeboCynthia H Y Fu, Mathilde Antoniades, Guray Erus, et al.
Pageof 17

Showing results (151-160 of 164) with videos related to

Sort By:
Pageof 17
Journal of the American Heart Association|December 30, 2022
Soluble Epoxide Hydrolase Derived Linoleic Acid Oxylipins, Small Vessel Disease Markers, and Neurodegeneration in StrokeDi Yu, Nuanyi Liang, Julia Zebarth, et al.
Journal of Neurology|June 25, 2025
Regional free-water diffusion is more strongly related to neuroinflammation than neurodegenerationVishaal Sumra, Mohsen Hadian, Allison A Dilliott, et al.
Neurorehabilitation and Neural Repair|June 3, 2023
Association of Dual-Task Gait Cost and White Matter Hyperintensity Burden Poststroke: Results From the ONDRIFrederico Pieruccini-Faria, Benjamin Cornish, Malcolm Binns, et al.
International Journal of Geriatric Psychiatry|March 16, 2024
Neuropsychiatric symptoms and brain morphology in patients with mild cognitive impairment, cerebrovascular disease and Parkinson disease: A cross sectional and longitudinal studyNeda Rashidi-Ranjbar, Nathan W Churchill, Sandra E Black, et al.
European Journal of Neurology|January 24, 2023
White matter hyperintensity burden predicts cognitive but not motor decline in Parkinson's disease: results from the Ontario Neurodegenerative Diseases Research InitiativeDaniela Cristina Carvalho de Abreu, Frederico Pieruccini-Faria, Yanina Sarquis-Adamson, et al.
Geroscience|March 16, 2022
Investigating the contribution of white matter hyperintensities and cortical thickness to empathy in neurodegenerative and cerebrovascular diseasesMiracle Ozzoude, Brenda Varriano, Derek Beaton, et al.
Brain Communications|March 27, 2023
Cognitive correlates of antisaccade behaviour across multiple neurodegenerative diseasesHeidi C Riek, Donald C Brien, Brian C Coe, et al.
Alzheimer'S Research & Therapy|June 20, 2023
White matter hyperintensities and smaller cortical thickness are associated with neuropsychiatric symptoms in neurodegenerative and cerebrovascular diseasesMiracle Ozzoude, Brenda Varriano, Derek Beaton, et al.
BMC Psychiatry|January 23, 2023
AI-based dimensional neuroimaging system for characterizing heterogeneity in brain structure and function in major depressive disorder: COORDINATE-MDD consortium design and rationaleCynthia H Y Fu, Guray Erus, Yong Fan, et al.
Nature. Mental Health|July 1, 2024
Neuroanatomical dimensions in medication-free individuals with major depressive disorder and treatment response to SSRI antidepressant medications or placeboCynthia H Y Fu, Mathilde Antoniades, Guray Erus, et al.
Pageof 17